drugset / Trial / NCT07586943
SKB118 Injection in Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, Phase I/II clinical study. The study is divided into two parts, the SKB118 monotherapy study and the SKB118 in combination with SKB264 study.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2029-12
- Completion
- 2030-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKB118 | Unknown | — | Intravenous |
| Subject | Sacituzumab Tirumotecan | Other / unclassified | — | Intravenous |